Karl Thor
Principal investigator, leads Dignify Therapeutics LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$4.0MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $4.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 1, 2018 | NIH | SBIR Phase II Development of a first-in-class therapeutic for producing 'on-demand' voiding | $2.0M | Dignify Therapeutics LLC |
| Sep 30, 2017 | NIH | SBIR Phase II An optimized NK2R agonist for 'on-demand' voiding | $1.8M | Dignify Therapeutics LLC |
| Sep 30, 2016 | NIH | SBIR Phase I Identification of an optimized NK2R agonist for 'on-demand' voiding | $276K | Dignify Therapeutics LLC |
Peer ranks
Federal funding#384
Awards as PI#822
Patents#273
Companies
- Dignify Therapeutics LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.